Abnormal CSF amyloid-β42 and tau levels in hip fracture patients without dementia.
Esther S OhKaj BlennowGeorge E BigelowSharon K InouyeEdward R MarcantonioKarin J NeufeldPaul B RosenbergJuan C TroncosoNae-Yuh WangHenrik ZetterbergFrederick E SieberConstantine G LyketsosPublished in: PloS one (2018)
A large proportion of older hip fracture patients have CSF evidence of AD pathology. Preoperative determination of AD biomarkers may play a crucial role in identifying persons without dementia who have underlying AD pathology in perioperative settings.